Urteste Granted U.S. Patent For Panuri Test In Diagnosis Of Pancreatic Cancer

Urteste S.A. (URT.WA) said it received a U.S. Patent and Trademark Office patent for its proprietary Panuri test for pancreatic cancer. The patent is a modest positive milestone that can strengthen IP defensibility, though the news does not indicate any immediate revenue or clinical outcome changes.

Analysis

Urteste S.A. (URT.WA) said it received a U.S. Patent and Trademark Office patent for its proprietary Panuri test for pancreatic cancer. The patent is a modest positive milestone that can strengthen IP defensibility, though the news does not indicate any immediate revenue or clinical outcome changes.